454
Views
3
CrossRef citations to date
0
Altmetric
Treatment

DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT)

, PhD, , MD, , MD, , MD, , MD, , BSc, , MPH, , MSc, , MD & , MD show all
Pages 1110-1118 | Received 15 Jan 2019, Accepted 17 Jun 2019, Published online: 11 Jul 2019

References

  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017;5:691–706.
  • Lewis A, Torvinen S, Dekhuijzen PNR, Chrystyn H, Watson AT, Blackney M, Plich A. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries. BMC Health Serv Res 2016;16:251.
  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy For the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; 2018 [accessed on 2019 May 10]. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2018 [accessed on 2019 May 10]. https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf.
  • Ramadan WH, Sarkis AT. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: an observational comparative study. Chron Respir Dis. 2017;14:309–320. doi: 10.1177/1479972316687209.
  • Cerveri I, Locatelli F, Zoia MC, Corsico A, Accordini S, de Marco R. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1999;14:288–294.
  • Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–384. doi: 10.2147/COPD.S3036.
  • Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108:358–365. doi: 10.1016/j.rmed.2013.09.021.
  • Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther. 2011;28:202–212. doi: 10.1007/s12325-010-0108-4.
  • Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604. doi: 10.1016/j.rmed.2007.11.003.
  • Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107:37–46. doi: 10.1016/j.rmed.2012.09.017.
  • Welch MJ, Nelson HS, Shapiro G, Bensch GW, Sokol WN, Smith JA, Parasuraman BM. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med. 2004;17:129–139. doi: 10.1089/0894268041457174.
  • Virchow JC, Rodriguez-Roisin R, Papi A, Shah TP, Gopalan G. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma. BMC Pulm Med. 2016;16:42.
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertension 2008;10:348–354. doi: 10.1111/j.1751-7176.2008.07572.x.
  • Krousel-Wood MA, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59–66.
  • Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64:258–263.
  • Lasmar L, Camargos P, Champs NS, Fonseca MT, Fontes MJ, Ibiapina C, Alvim C, Moura JA. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 2009;64:784–789. doi: 10.1111/j.1398-9995.2008.01877.x.
  • Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, Green RH. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012;67:751–753. doi: 10.1136/thoraxjnl-2011-201096.
  • Baddar S, Jayakrishnan B, Al-Rawas OA. Asthma control: importance of compliance and inhaler technique assessments. J Asthma 2014;51:429–434. doi: 10.3109/02770903.2013.871558.
  • Marceau C, Lemière C, Berbiche D, Perreault S, Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol. 2006;118:574–581. doi: 10.1016/j.jaci.2006.06.034.
  • Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Fauro D, Lanfear DE, Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128:1185–1191.e2. doi: 10.1016/j.jaci.2011.09.011.
  • Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64:939–943. doi: 10.1136/thx.2009.113662.
  • Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332–336. doi: 10.1056/NEJM200008033430504.
  • Janežič A, Locatelli I, Kos M. Criterion validity of 8-item Morisky medication adherence scale in patients with asthma. PLoS One 2017;12:e0187835. doi: 10.1371/journal.pone.0187835.
  • Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004;7:204–215. doi: 10.1111/j.1524-4733.2004.72252.x.
  • Davis KH, Su J, González JM, Trudeau JJ, Nelson LM, Hauber B, Hollis KA, et al. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health Qual Life Outcomes 2017;15:201.
  • Price DB, Thomas V, Richard Dekhuijzen PN, Bosnic-Anticevich S, Roche N, Lavorini F, Raju P, Freeman D, Nicholls C, Small IR, et al. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study. BMC Pulm Med. 2018;18:107.
  • Gillissen A, Gessner C, Hechenbichler K, Herth FJF, Juenemann R, Kanniess F, Kardos P, Lommatzsch M, Schneidereit R, Windisch W. Patient satisfaction and clinical outcomes with budesonide plus formoterol Spiromax for asthma and chronic obstructive pulmonary disease (COPD): a real-world, observational trial. Respiration 2019;97:292–301.
  • Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26. doi: 10.1186/s40413-015-0075-y.
  • De Backer W, Devolder A, Poli G, Acerbi D, Monno R, Herpich C, Sommerer K, Meyer T, Mariotti F. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv. 2010;23:137–148. doi: 10.1089/jamp.2009.0772.
  • Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, et al. Inhaler errors in the CRITIKAL study: type, frequency and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5:1071–1081.e9. doi: 10.1016/j.jaip.2017.01.004.
  • Clarenbach CF, Nicod LP, Kohler M. Real-world asthma management with inhaler devices in Switzerland—results of the asthma survey. J Thorac Dis. 2016;8:3096–3104. doi: 10.21037/jtd.2016.11.95.
  • Basheti I, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Counseling about Turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005;50:617–623.
  • Sandler N, Holländer J, Långström D, Santtila P, Saukkonen A, Torvinen S. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler). BMJ Open Resp Res. 2016;3:e000119. doi: 10.1136/bmjresp-2015-000119.
  • Rönmark P, Jagorstrand B, Safioti G, Menon S, Bjermer L. Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers. Eur Clin Respir J. 2018;5:1529536. doi: 10.1080/20018525.2018.1529536.
  • Bosnic-Anticevich S, Callan C, Chrystyn H, Lavorini F, Nikolaou V, Kritikos V, Dekhuijzen PNR, Roche N, Bjermer L, Rand C, et al. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices. J Asthma 2018;55:79–88. doi: 10.1080/02770903.2017.1310227.
  • Tedia YG, Bautista LE. Factors associated with false-positive self-reported adherence to antihypertensive drugs. J Hum Hypertens. 2017;31:320–326. doi: 10.1038/jhh.2016.80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.